V4L (p.Val4Leu) variant of PCSK9 (Proprotein convertase subtilisin/kexin type 9)

V4L (p.Val4Leu) in PCSK9 (Proprotein convertase subtilisin/kexin type 9) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Familial hypercholesterolemia. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes population frequency data, published literature, and structural context.

V4L (p.Val4Leu) variant details